Form 4: Alkami Technology CFO W. Bryan Hill Executes Option and Sells Shares
SEC Form 4
W. Bryan Hill, CFO of Alkami Technology, exercised stock options and sold 100,000 shares of common stock on June 17, 2024, according to a Form 4 filing with the SEC.
Summary
- On June 17, 2024, W. Bryan Hill, the Chief Financial Officer of Alkami Technology, Inc. (ALKT), exercised options to purchase 100,000 shares of common stock at a price of $2.34 per share.
- Simultaneously, Hill sold 100,000 shares of Alkami Technology common stock at a weighted average price of $25.7199, with individual sales prices ranging from $25.35 to $26.19.
- These transactions were executed under a pre-arranged Rule 10b5-1 trading plan adopted on March 11, 2024.
- Following these transactions, Hill directly owns 489,340 shares of Alkami Technology common stock and holds options for 600,000 shares.
Sentiment
Score: 5
Explanation: Neutral sentiment as it's a routine disclosure of insider trading activity under a pre-arranged plan.
Industry Context
This filing is a routine disclosure of insider transactions. It's common for executives to exercise stock options and sell shares, especially under pre-arranged trading plans like Rule 10b5-1, which allows insiders to trade without being accused of acting on non-public information.
Comparison to Industry Standards
- Comparing this transaction to similar insider sales at comparable fintech companies would require analyzing Form 4 filings for companies like Blend Labs (BLND), nCino (NCNO), or DLocal (DLO).
- Typical executive compensation packages in the tech industry often include stock options, making these types of transactions relatively common.
- The use of a 10b5-1 plan is a standard practice to mitigate concerns about insider trading.
Stakeholder Impact
- The sale of shares by a high-ranking executive could be perceived negatively by some investors, but the existence of a 10b5-1 plan mitigates this concern.
- The transactions have no immediate impact on employees, customers, suppliers, or creditors.
Key Dates
| Date | Description |
|---|---|
| 03/11/2024 | Date of adoption of Rule 10b5-1 trading plan |
| 06/17/2024 | Date of stock option exercise and share sale |
| 06/18/2024 | Date of Form 4 filing |
| 04/01/2029 | Expiration date of stock options |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.